The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications

Z Mao, B Wang, T Zhang, B Cui - Cell Death & Disease, 2023 - nature.com
Cervical cancer (CC) is a gynecological neoplasm with the highest incidence rate, primarily
attributed to the persistent infection of high-risk Human papillomavirus (HPV). Despite …

[HTML][HTML] Regulation of the aryl hydrocarbon receptor in cancer and cancer stem cells of gynecological malignancies: An update on signaling pathways

L Therachiyil, OJ Hussein, S Uddin… - Seminars in Cancer …, 2022 - Elsevier
Gynecological malignancies are a female type of cancers that affects the reproductive
system. Cancer metastasis or recurrence mediated by cellular invasiveness occurs at …

piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner

Q ** Approach
AC Hachey, AD Fenton, DK Heidary… - Journal of Medicinal …, 2022 - ACS Publications
Cytochrome P450 1B1 (CYP1B1) is a potential drug target in cancer research that is
overexpressed in several solid tumors but is present only at low levels in healthy tissues. Its …

ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma …

X Ding, A Wan, X Qi, K Jiang, Z Liu… - Current Gene …, 2024 - benthamdirect.com
Background: The role of Zinc Finger Protein 695 (ZNF695) is unclear in cervical squamous
cell carcinoma and endocervical adenocarcinoma (CESC). Objective: The objective of this …

Design of Novel 2-Phenylquinazolin-4-amines as Selective CYP1B1 Inhibitors for Overcoming Paclitaxel Resistance in A549 Cells

M Yang, F Yang, X Huang, J Cai, Y Zhang… - Journal of Medicinal …, 2024 - ACS Publications
Cytochrome P450 1B1 (CYP1B1) contributes to the metabolic inactivation of
chemotherapeutics when overexpressed in tumor cells. Selective inhibition of CYP1B1 …